[Federal Register Volume 59, Number 48 (Friday, March 11, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-5710]


[[Page Unknown]]

[Federal Register: March 11, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE
 

Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.43(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 8, 1994, Sanofi 
Winthrop LP, DBA Sterling Organics, 33 Riverside Avenue, Rensselaer, 
New York 12144, made application to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the Schedule II basic 
class of controlled substance Meperidine (9230).
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than April 11, 1994.

    Dated: March 3, 1994
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-5710 Filed 3-10-94; 8:45 am]
BILLING CODE 4410-09-M